Radiochemical Research Publications

Last Updated: 05/21/2015

“Characterization and Evaluation of a DOTA-conjugated Bombesin/RGD-Antagonists for Prostate Cancer Tumor Imaging and Therapy”, Stott Reynolds, T., Schehr, R., Liu, D., Xu, J., Miao, Y., Hoffman, T.J., Rold, T.L., Lewis, M.R., Smith, C.J., Nuclear Medicine and Biology, 42 (2), 99, 2015

“Diversification in the supply chain of 99Mo ensures a future for 99mTc”, Cutler, C.S., Schwarz, S.W., Journal of Nuclear Medicine, 55 (7), 1208, 2014

“Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution”, Black, K.C.L., Wang, Y., Luehmann, H.P., Cai, X., Xing, W., Pang, B., Zhao, Y., Cutler, C.S., Wang, L.V., Liu, Y., Xia, Y., ACS Nano, 8 (5), 4385, 2014

“Chromatographic separation of selenium and arsenic: A potential 72Se/72As generator”, Wycoff, D.E., Gott, M.D., DeGraffenreid, A.J., Morrow, R.P., Sisay, N., Embree, M.F., Ballard, B., Fassbender, M.E., Cutler, C.S., Ketring, A.R., Jurisson, S.S., Journal of Chromatography A, 1340, 109, 2014

“166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: Comparison with 188Re radiolabel”, Thompson, S., Ballard, B., Jiang, Z., Revskaya, E., Sisay, N., Miller, W.H., Cutler, C.S., Dadachova, E., Francesconi, L.C., Nuclear Medicine and Biology, 41 (3), 276, 2014

“Radiochemical study of re/w adsorption behavior on a strongly basic anion exchange resin”, Gott, M.D., Ballard, B.D., Redman, L.N., Maassen, J.R., Taylor, W.A., Engle, J.W., Nortier, F.M., Birnbaum, E.R., John, K.D., Wilbur, D.S., Cutler, C.S., Ketring, A.R., Jurisson, S.S., Fassbender, M.E., Radiochimica Acta, 102 (4), 325, 2014

“Specific activity measurement of 64Cu: A comparison of methods”, Mastren, T., Guthrie, J., Eisenbeis, P., Voller, T., Mebrahtu, E., Robertson, J.D., Lapi, S.E., Applied Radiation and Isotopes, 90, 117, 2014

“Bombesin peptide conjugated gold nanocages internalize via clathrin mediated endocytosis”, Suresh, D., Zambre, A., Chanda, N., Hoffman, T.J., Smith, C.J., Robertson, J.D., Kannan, R., Bioconjugate Chemistry, 25 (8), 1565, 2014

“Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component”, Kudgus, R.A., Walden, C.A., McGovern, R.M., Reid, J.M., Robertson, J.D., Mukherjee, P., Scientific Reports, 4, , 2014

“Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres”, You, J., Zhou, J., Zhou, M., Liu, Y., Robertson, J.D., Liang, D., Van Pelt, C., Li, C., Particle and Fibre Toxicology, 11 (1), , 2014

“LnPO4 nanoparticles doped with Ac-225 and sequestered daughters for targeted alpha therapy”, McLaughlin, M.F., Robertson, D., Pevsner, P.H., Wall, J.S., Mirzadeh, S., Kennel, S.J., Cancer Biotherapy and Radiopharmaceuticals, 29 (1), 34, 2014

“A Heterodimeric [64Cu-NO2A-RGD-Glu-6-Ahx-RM2] αvβ3/GRPr-targeting Antagonist Radiotracer for PET Imaging of Prostate Tumors”, Durkan, K., Jiang, Z., Rold, T.L., Sieckman, G.L., Hoffman, T.J., Bandari, R.J., Szczodroski, A.F., Liu, L., Miao, Y., Stott Reynolds, T., Smith, C.J., Nuclear Medicine and Biology, 41 (2), 133, 2014

“Novel Agents for Molecular Imaging and Possible Therapy of Human Cancers”, Smith, C.J., Austin Journal of Nuclear Medicine and Radiotherapy, 1 (2), 3, 2014

“Synthesis and Biological Evaluation of Copper-64 Radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a Novel Bivalent Targeting Vector Having Affinity for Two Distinct Biomarkers (GRPr/PSMA) of Prostate Cancer”, Bandari, R.P., Jiang, Z., Stott Reynolds, T., Bernskoetter, N.E., Connors, J.P., Szczodroski, A.F., Bassuner, K.J., Kirkpatrick, D.L., Rold, T.L., Sieckman, G.L., Hoffman, T.J., Smith, C.J., Nuclear Medicine and Biology, 41 (4), 355, 2014

“Gold-coated lanthanide phosphate nanoparticles for an 225Ac in vivo alpha generator”, McLaughlin, M.F., Woodward, J., Boll, R.A., Rondinone, A.J., Mirzadeh, S., Robertson, J.D., Radiochimica Acta, 101 (9), 595, 2013

“Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle”, Arvizo, R.R., Saha, S., Wang, E., Robertson, J.D., Bhattacharya, R., Mukherjee, P., Proceedings of the National Academy of Sciences of the United States of America, 110 (17), 6700, 2013

“Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics”, Kudgus, R.A., Szabolcs, A., Khan, J.A., Walden, C.A., Reid, J.M., Robertson, J.D., Bhattacharya, R., Mukherjee, P., PLoS ONE, 8 (3), e57522, 2013

“Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy”, McLaughlin, M.F., Woodward, J., Boll, R.A., Wall, J.S., Rondinone, A.J., Kennel, S.J., Mirzadeh, S., Robertson, J.D., PLoS ONE, 8 (1), e54531, 2013

“The use of 111Ag as a tool for studying biological distribution of silver-based antimicrobials”, Aweda, T.A., Ikotun, O., Mastren, T., Cannon, C.L., Wright, B., Youngs, W.J., Cutler, C., Guthrie, J., Lapi, S.E., MedChemComm, 4 (6), 1015, 2013

“Proton irradiation parameters and chemical separation procedure for the bulk production of high-specific-activity 186gRe using WO3 targets”, Fassbender, M.E., Ballard, B., Birnbaum, E.R., Engle, J.W., John, K.D., Maassen, J.R., Nortier, F.M., Lenz, J.W., Cutler, C.S., Ketring, A.R., Jurisson, S.S., Wilbur, D.S., Radiochimica Acta, 101 (5), 339, 2013

“Intrinsically radiolabeled multifunctional cerium oxide nanoparticles for in vivo studies”, Yang, L., Sundaresan, G., Sun, M., Jose, P., Hoffman, D., McDonagh, P.R., Lamichhane, N., Cutler, C.S., Perez, J.M., Zweit, J., Journal of Materials Chemistry B, 1 (10), 1421, 2013

“Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging”, Wang, Y., Liu, Y., Luehmann, H., Xia, X., Wan, D., Cutler, C., Xia, Y., Nano Letters, 13 (2), 581, 2013

“Radiometals for combined imaging and therapy”, Cutler, C.S., Hennkens, H.M., Sisay, N., Huclier-Markai, S., Jurisson, S.S., Chemical Reviews, 113 (2), 858, 2013

“Nanoparticles and phage display selected peptides for imaging and therapy of cancer”, Cutler, C.S., Chanda, N., Shukla, R., Sisay, N., Cantorias, M., Zambre, A., McLaughlin, M., Kelsey, J., Upenandran, A., Robertson, D., Deutscher, S., Kannan, R., Katti, K., Recent Results in Cancer Research, 194, 133, 2013

“177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma”, Jiang, L., Miao, Z., Liu, H., Ren, G., Bao, A., Cutler, C.S., Shi, H., Cheng, Z., Nuclear Medicine Communications, 34 (9), 909, 2013

“Advancing the translation of optical imaging agents for clinical imaging”, Sevick-Muraca, E.M., Akers, W.J., Joshi, B.P., Luker, G.D., Cutler, C.S., Marnett, L.J., Contag, C.H., Wang, T.D., Azhdarinia, A., Biomedical Optics Express, 4 (1), 160, 2013

“Molecular Imaging Probes Based Upon Bombesin Peptide”, Smith, C.J., Nanda, P.K., Ma, L., Stott Reynolds, T., Hoffman, T.J., Bernskoetter, N.E., Jiang, Z., Amino Acids; The Forum for Amino Acid, Peptide, and Protein Research, 45 (3), 608, 2013

“Near-infrared Fluorescence Imaging of Gastrin Releasing Peptide Receptor Targeting in Prostate Cancer Lymph Node Metastases”, Cai, Q-Y., Yu, P., Besch-Williford, C., Smith, C.J., Sieckman, G., Hoffman, T.J., Ma, L., The Prostate, 73, 842, 2013

“Synthesis and Selective Radiolabeling Strategies for Production of [90Y-DOTA-64Cu-NOTA-8-Aoc-BBN(7-14)NH2] Conjugate; a Dual Negatron/Positron Emitting Radioligand.” Journal of Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-metal Compounds”, Wienhoff, B.E., Prasanphanich, A., Lane, S.R., Nanda, P.K., Sieckman, G.L., Smith, C.J., Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-metal Compounds, 43 (2), 178, 2013

“Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imaging”, Zhang, X., Yue, Z., Lu, B.-Y., Vazquez-Flores, G.J., Yuen, J., Figueroa, S.D., Gallazzi, F., Cutler, C., Quinn, T.P., Lacy, J.L., Current Radiopharmaceuticals, 5 (4), 329, 2012

“Laminin receptor specific therapeutic gold nanoparticles ( 198AuNP-EGCg) show efficacy in treating prostate cancer”, Shuklaa, R., Chanda, N., Zambre, A., Upendran, A., Katti, K., Kulkarni, R.R., Nune, S.K., Casteel, S.W., Smith, C.J., Vimal, J., Boote, E., Robertson, J.D., Kan, P., Engelbrecht, H., Watkinson, L.D., Carmack, T.L., Lever, J.R., Cutler, C.S., Caldwell, C., Kannan, R., Katti, K.V., Proceedings of the National Academy of Sciences of the United States of America, 109 (31), 12426, 2012

“Switching the targeting pathways of a therapeutic antibody by nanodesign”, Bhattacharyya, S., Singh, R.D., Pagano, R., Robertson, J.D., Bhattacharya, R., Mukherjee, P., Angewandte Chemie – International Edition, 51 (7), 1563, 2012

“177Lu-DO3A-HSA-Z EGFR:1907: Characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas”, Hoppmann, S., Qi, S., Miao, Z., Liu, H., Jiang, H., Cutler, C.S., Bao, A., Cheng, Z., Journal of Biological Inorganic Chemistry, 17 (5), 709, 2012

“Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: A perspective study for enhancing the 90Y and 177Lu labeling conditions”, Asti, M., Tegoni, M., Farioli, D., Iori, M., Guidotti, C., Cutler, C.S., Mayer, P., Versari, A., Salvo, D., Nuclear Medicine and Biology, 39 (4), 509, 2012

“Selenium-72 formation via natBr(p,x) induced by 100MeV Protons: Steps towards a novel 72Se/ 72As generator system”, Ballard, B., Wycoff, D., Birnbaum, E.R., John, K.D., Lenz, J.W., Jurisson, S.S., Cutler, C.S., Nortier, F.M., Taylor, W.A., Fassbender, M.E., Applied Radiation and Isotopes, 70 (4), 595, 2012

“Investigation into the extraction speciation of rare-earth radioisotopes from aqueous solution using polyoxometalates”, Burton-Pye, B.P., Jones, I., Cutler, C.S., Howell, R.C., Francesconi, L.C., Inorganica Chimica Acta, 380 (1), 236, 2012

“Functionalized radioactive gold nanoparticles in tumor therapy”, Kannan, R., Zambre, A., Chanda, N., Kulkarni, R., Shukla, R., Katti, K., Upendran, A., Cutler, C., Boote, E., Katti, K.V., Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 4 (1), 42, 2012

“64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: A Heterodimeric Targeting Vector for Positron-emission Tomography Imaging of Prostate Cancer”, Jackson, A.B., Nanda, P.K., Rold, T.L., Sieckman, G.L., Szczodroski, A.F., Hoffman, T.J., Chen, X., Smith, C.J., Nuclear Medicine and Biology, 39, 377, 2012

“Bombesin Analogues for Gastrin-releasing Peptide Receptor Imaging”, Nanda, P.K., Pandey, U., Bottenus, B.N., Rold, T.L., Sieckman, G.L., Hoffman, T.J., Smith, C.J., Nuclear Medicine and Biology, 39, 461, 2012

“Comparison of Two Peptide Radiotracers for Prostate Carcinoma Targeting”, Faintuch, B.L., Oliveira, E.A., Fernandez, E.G., Teodoro, R., Moro, A.M., Nanda, P.K., Smith, C.J., Clinics, 67 (2), 163, 2012

“Development of Receptor-avid Peptide Radiotracers for Targeting of Human Cancers”, Volkert, W.A., Quinn, T.P., Smith, C.J., Hoffman, T.J., Targeted Molecular Imaging M.J. Welch and W.C. Eckelman Eds., , 337, 2012

“PET Imaging of GRPR-expressing Tumors With an 18F-labeled Bombesin Analog”, Dijkgraaf, I., Franssen, G.M., McBride, W.J., D’Souza, C.A., Smith, C.J., Goldenberg, D.M., Oyen, W.J.G., Boerman, O.C., Journal of Nuclear Medicine, 53 (6), 947, 2012

“Positron-emission Tomography (PET) Imaging Agents for Diagnosis of Human Prostate Cancer: “Agonist Versus Antagonist Ligands” In Vivo. International Journal of Experimental and Clinical Pathophysiology and Drug Research”, Nanda, P.K., Rold, T.L., Sieckman, G.L., Szczodroski, A.F., Hoffman, T.J., Rogers, B.E., Wienhoff, B.E., Smith, C.J., In Vivo International Journal of Experimental and Clinical Pathophysiology and Drug Research, 26, 583, 2012

“Radiotracers for Different Angiogenesis Receptors in a Melanoma Model”, Oliveira, E.A., Faintuch, B.L., Nunez, E.G.F., Moro, A.M., Nanda, P.K., Smith, C.J., Melanoma Research, 22 (1), 45, 2012

“Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives”, Bigott-Hennkens, H.M., Dannoon, S.F., Noll, S.M., Ruthengael, V.C., Jurisson, S.S., Lewis, M.R., Nuclear Medicine and Biology, 38 (4), 549, 2011

“Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu”, Mohsin, H., Jia, F., Bryan, J.N., Sivaguru, G., Cutler, C.S., Ketring, A.R., Miller, W.H., Simón, J., Frank, R.K., Theodore, L.J., Axworthy, D.B., Jurisson, S.S., Lewis, M.R., Bioconjugate Chemistry, 22 (12), 2444, 2011

“Efficient delivery of gold nanoparticles by dual receptor targeting”, Bhattacharyya, S., Khan, J.A., Curran, G.L., Robertson, J.D., Bhattacharya, R., Mukherjee, P., Advanced Materials, 23 (43), 5034, 2011

“Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles”, Arvizo, R.R., Miranda, O.R., Moyano, D.F., Walden, C.A., Giri, K., Bhattacharya, R., Robertson, J.D., Rotello, V.M., Reid, J.M., Mukherjee, P., PLoS ONE, 6 (9), e24374, 2011

“A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity”, Bhattacharyya, S., Gonzalez, M., Robertson, J.D., Bhattacharya, R., Mukherjee, P., Chemical Communications, 47 (30), 8530, 2011

“In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma”, Ballard, B., Jiang, Z., Soll, C.E., Revskaya, E., Cutler, C.S., Dadachova, E., Francesconi, L.C., Cancer Biotherapy and Radiopharmaceuticals, 26 (5), 547, 2011

“Development of PET molecular targeting agents with gallium-68”, Cutler, C.S., Sisay, N., Cantorias, M., Galazzi, F., Quinn, T.P., Smith, C.J., Radiochimica Acta, 99 (10), 641, 2011

“Chemical and biological evaluation of scandium(III)- polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals”, Huclier-Markai, S., Sabatie, A., Ribet, S., Kubí?ek, V., Paris, M., Vidaud, C., Hermann, P., Cutler, C.S., Radiochimica Acta, 99 (10), 653, 2011

“Components of a curriculum for molecular imaging scientists”, Zinn, K.R., Anderson, C.J., Bradbury, M., Cutler, C.S., Peterson, T.E., Morgan, D.E., Price, J.C., Graham, M.M., Contag, C.H., Wittstrom, K., Norenberg, J.P., Journal of Nuclear Medicine, 52 (4), 650, 2011

“Tetradentate bis-phosphine ligands (P2N2 and P2S2) and their Rh(III), Ni(II) and 105Rh Complexes: X-ray crystal structures of trans-[RhCl2(L2)]PF6, [Ni(L2)](PF6)2 and μ-O2SO2-[Ni(L5)]2(PF6)2”, Cagnolini, A., Ballard, B., Engelbrecht, H.P., Rold, T.L., Barnes, C., Cutler, C., Hoffman, T.J., Kannan, R., Katti, K., Jurisson, S.S., Nuclear Medicine and Biology, 38 (1), 63, 2011

“Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea”, Sharma, A., Tandon, A., Tovey, J.C.K., Gupta, R., Robertson, J.D., Fortune, J.A., Klibanov, A.M., Cowden, J.W., Rieger, F.G., Mohan, R.R., Nanomedicine: Nanotechnology, Biology, and Medicine, 7 (4), 505, 2011

“Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo”, Khan, J.A., Kudgus, R.A., Szabolcs, A., Dutta, S., Wang, E., Cao, S., Curran, G.L., Shah, V., Curley, S., Mukhopadhyay, D., Robertson, J.D., Bhattacharya, R., Mukherjee, P., PLoS ONE, 6 (6), e20347, 2011

“Clinical Translation of Radioactive Gold Nanoparticle-based Nanoceutical (EGCG-198AuNP) for Prostate Tumor Therapy”, Shukla, R., Zambre, A., Chandra, N., Kan, P., Engelbrecht, H., Cutler, C.S., Lever, J.R., Smith, C.J., Caldwell, C.W., Katti, K., Upendran, A., Kannan, R., Katti, K.V., Journal of Labelled Compounds and Radiopharmaceuticals, , O-089, 2011

“Design and Synthesis of a Bombesin Peptide-Conjugated Tripodal Phosphino Dithioether Ligand Topology for the Stabilization of fac-[M(CO)3]+ Core (M = 99mTc or Re)”, Kannan, R., Pillarsetty, N., Gali, H., Hoffman, T.J., Volkert, W.A., Barnes, C.L., Jurisson, S.S., Smith, C.J., Katti, K.V., Inorganic Chemistry, 50, 6210, 2011

“Evaluation of Receptor Affinity of Au-198-Starch-Nanoparticles Conjugated to Bombesin”, McLaughlin, M., Chanda, N., Lever, J.R., Smith, C.J., Kannan, R., Katti, K., Katti, K.V., Cutler, C.S., Journal of Labelled Compounds and Radiopharmaceuticals, , P-460, 2011

“Improvement of Al18F-labeling of Peptides and In Vivo Characterization”, Laverman, P., Dijkgraaf, I., McBride, W.J., D’Souza, C.A., Eek, A., Smith, C.J., Sharkey, R.M., Oyen, W.J.G., Goldenberg, D.M., Boerman, O.C., Journal of Labelled Compounds and Radiopharmaceuticals, , P-370, 2011

“Molecular Imaging of Breast Cancer Tissue via Site-directed Radiopharmaceuticals”, Jackson, A., Retzloff, L., Nanda, P., Smith, C.J., Breast Cancer Cells, , 277, 2011

“Multifunctional Tricarbonyl M(I) (M = Re, 99mTc) Complexes Bearing an Acridine Orange Intercalator and Bombesin Analogues: Synthesis, Characterization, and Cell Studies”, Esteves, T., Marques, F., Paulo, A., Rino, J., Nanda, P., Smith, C.J., Santos, I., Journal of Biological Inorganic Chemistry, 18 (8), 1141, 2011

“Optimization, Biological Evaluation, and MicroPET Imaging of Copper-64-Labeled Agonists, [64Cu-NO2A-X-BBN(7-14)NH2], in a Prostate Tumor Xenografted Mouse Model.”, Lane, S.R.; Nanda, P.K.; Rold, T.L.; Sieckman, G.L.; Figueroa, S.D.; Hoffman, T.J.; Jurisson, S.S.; and Smith, C.J., Nucl. Med. Biol., 37, 751, 2010

“Comparative Evaluation of 64Cu-labeled E. Coli Heat-stable Enterotoxin Analogs for PET Imaging of Colorectal Cancer.”, Liu, D.; Overbey, D.; Watkinson, L.D.; Smith, C.J.; Figueroa, S.D.; Hoffman, T.J.; Forte, L.R.; Volkert, W.A.; and Giblin, M.F., Bioconjugate Chem., 21, 1171, 2010

“Evaluation of [99mTc-(CO)3-X-Y-Bombesin(7-14)NH2] Conjugates for Targeting Gastrin Releasing Peptide Receptors Over-expressed on Breast Carcinoma.”, Retzloff, L.B.; Heinzke, L.; Figureoa, S.D.; Sublett, S.V.; Sieckman, G.L.; Rold, T.L.; Hoffman, T.J.; and Smith, C.J., Anticancer Research, 30 (1), 19, 2010

“Radiolabeled Regulatory Peptides for Imaging and Therapy.”, Nanda, P.K.; Lane, S.R.; Retzloff, L.B.; Pandey, U.S.; and Smith, C.J., Current Opinion in Endocrinology and Diabetes, 17, 69, 2010

“In vitro structure-activity relationship of Re-cyclized octreotide analogues”, Dannoon, S.F., Bigott-Hennkens, H.M., Ma, L., Gallazzi, F., Lewis, M.R., Jurisson, S.S., Nuclear Medicine and Biology, 37 (5), 527, 2010

“The complexation of rhodium(III) with acyclic diaminedithioether (DADTE) ligands”, Akgun, Z., Engelbrecht, H., Fan, K.-H., Barnes, C.L., Cutler, C.S., Jurisson, S.S., Lever, S.Z., Dalton Transactions, 39 (42), 10169, 2010

“Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity”, Chanda, N., Kattumuri, V., Shukla, R., Zambre, A., Katti, K., Upendran, A., Kulkarni, R.R., Kan, P., Fent, G.M., Casteel, S.W., Smith, C.J., Boote, E., Robertson, J.D., Cutler, C., Lever, J.R., Katti, K.V., Kannan, R., Proceedings of the National Academy of Sciences of the United States of America, 107 (19), 8760, 2010

“Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice”, Chanda, N., Kan, P., Watkinson, L.D., Shukla, R., Zambre, A., Carmack, T.L., Engelbrecht, H., Lever, J.R., Katti, K., Fent, G.M., Casteel, S.W., Smith, C.J., Miller, W.H., Jurisson, S., Boote, E., Robertson, J.D., Cutler, C., Dobrovolskaia, M., Kannan, R., Katti, K.V., Nanomedicine: Nanotechnology, Biology, and Medicine, 6 (2), 201, 2010

“Gold(III) bis-thiosemicarbazonato complexes: synthesis, characterization, radiochemistry and X-ray crystal structure analysis”, Bottenus, B.N., Kan, P., Jenkins, T., Ballard, B., Rold, T.L., Barnes, C., Cutler, C., Hoffman, T.J., Green, M.A., Jurisson, S.S., Nuclear Medicine and Biology, 37 (1), 41, 2010

“Comparison of systemic toxicities of177Lu-DOTMP and 153Sm-EDTMP administered intravenously at equivalent skeletal doses to normal dogs”, Bryan, J.N., Bommarito, D., Kim, D.Y., Berent, L.M., Bryan, M.E., Lattimer, J.C., Henry, C.J., Engelbrecht, H., Ketring, A., Cutler, C., Journal of Nuclear Medicine Technology, 37, 45, 2009

“Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors”, Cantorias, M.V., Figueroa, S.D., Quinn, T.P., Lever, J.R., Hoffman, T.J., Watkinson, L.D., Carmack, T.L., Cutler, C.S., Nuclear Medicine and Biology, 36, 505, 2009

“True Radiotracers: Copper-64 Targeting Vectors Based Upon Bombesin Peptide.”, Hoffman, T.J.; and Smith, C.J., Nucl. Med. Biol., 36, 579, 2009

“In Vitro and In Vivo Analysis of [64Cu-NOTA-8-Aoc-BBN(7-14)NH2]: a Site-Directed Radiopharmaceutical for PET Imaging of T-47D Human Breast Cancer Tumors.”, Prasanphanich, A.; Retzloff, L.; Lane, S.R.; Nanda, P.K.; Sieckman, G.L.; Rold, T.L.; Ma, L.; Figueroa, S.D.; Sublett, S.V.; Hoffman, T.J.; and Smith, C.J., Nucl. Med. Biol., 36 (2), 171, 2009

“Advances in radiopharmacology and radiopharmacy: Lions, tigers and bears oh my!”, Cutler, C.S., Schwarz, S., Quarterly Journal of Nuclear Medicine and Molecular Imaging, 53 (4), 357, 2009

“Preparation and use of carrier free 105Rh”, Ballard, B., Engelbrecht, H., Cutler, C., Jurisson, S., Transactions of the American Nuclear Society, 98, 848, 2008

“68Ga-bombesin antagonist for imaging prostate cancer”, Bottenus, B.N., Garrison, J.C., Rold, T.L., Sieckman, G.L., Figueroa, S.D., Sublett, S.V., Engelbrecht, H., Cutler, C.S., Jurisson, S.S., Hoffman, T.J., Transactions of the American Nuclear Society, 98, 802, 2008

“Comparison of methods to produce high specific activity radiolanthanides”, Cutler, C.S., Engelbrecht, H., Embree, M., Wilder, S., Cantorias, M., Ketring, A., Transactions of the American Nuclear Society, 98, 907, 2008

“Imagine the imagery: Opportunities and challenges”, Cutler, C.S., McQuarrie, S., Smith, S.V., Quarterly Journal of Nuclear Medicine and Molecular Imaging, 52, 212, 2008

“Cytochrome P450 and radiopharmaceutical metabolism”, Giron, M.C., Portolan, S., Bin, A., Mazzi, U., Cutler, C.S., Quarterly Journal of Nuclear Medicine and Molecular Imaging, 52, 254, 2008

“Radiometal complexes: Characterization and relevant in vitro studies”, Jurisson, S., Cutler, C., Smith, S.V., Quarterly Journal of Nuclear Medicine and Molecular Imaging, 52, 222, 2008

“Murr-production and promotion of radioisotopes for medical applications since 1966”, Ketring, A.R., Cutler, C.S., Ehrhardt, G.J., Transactions of the American Nuclear Society, 98, 871, 2008

“Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging”, Neubauer, A.M., Myerson, J., Caruthers, S.D., Hockett, F.D., Winter, P.M., Chen, J., Gaffney, P.J., Robertson, J.D., Lanza, G.M., Wickline, S.A., Magnetic Resonance in Medicine, 60, 1066, 2008

“Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging”, Neubauer, A.M., Sim, H., Winter, P.M., Caruthers, S.D., Williams, T.A., Robertson, J.D., Sept, D., Lanza, G.M., Wickline, S.A., Magnetic Resonance in Medicine, 60, 1353, 2008

“Three-dimensional MR mapping of angiogenesis with α5β1(αvβ3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model”, Schmieder, A.H., Caruthers, S.D., Zhang, H., Williams, T.A., Robertson, J.D., Wickline, S.A., Lanza, G.M., FASEB Journal, 22, 4179, 2008

“Preparation and use of carrier free 161Tb”, Somashekar, C., Spatola, B., Wilder, S., Cantorias, M., Jurisson, S., Cutler, C., Transactions of the American Nuclear Society, 98, 849, 2008

“Radiolabeled Bombesin Analogs for Prostate Cancer Diagnosis: Preclinical Studies.”, Faintuch, B.L.; Teodoro, R.; Duatti, A.; Morganti, L.; Muramoto, E.; Faintuch, S.; and Smith, C.J., Nucl. Med. Biol., 35, 401, 2008

“99mTc(CO)3-DTMA (DTMA = DIETHYLENETRIAMINE MONOACETATE) Bombesin Conjugates Having High Affinity for the GRP Receptor.”, Lane, S.R.; Veerendra, B.; Rold, T.L.; Sieckman, G.L.; Hoffman, T.J.; Jurisson, S.S.; and Smith, C.J., Nucl. Med. Biol., 35 (3), 263, 2008

“Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: In vivo pharmacokinetics and X-ray-contrast-imaging studies”, Kattumuri, V., Katti, K., Bhaskaran, S., Boote, E.J., Casteel, S.W., Fent, G.M., Robertson, D.J., Chandrasekhar, M., Kannan, R., Katti, K.V., Small, 3, 333, 2007

“Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3”, Mohsin, H., Fitzsimmons, J., Shelton, T., Hoffman, T.J., Cutler, C.S., Lewis, M.R., Athey, P.S., Gulyas, G., Kiefer, G.E., Frank, R.K., Simon, J., Lever, S.Z., Jurisson, S.S., Nuclear Medicine and Biology, 34, 493, 2007

“Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents”, Neubauer, A.M., Caruthers, S.D., Hockett, F.D., Cyrus, T., Robertson, J.D., Allen, J.S., Williams, T.D., Fuhrhop, R.W., Lanza, G.M., Wickline, S.A., Journal of Cardiovascular Magnetic Resonance, 9, 565, 2007

“[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] Conjugate: A Novel Targeting Vector for Positron Emission Tomographic Imaging of Gastrin Releasing Peptide Receptor-Expressing Tissues.”, Prasanphanich, A.; Nanda, P.K.; Rold, T.L.; Ma, L.; Lewis, M.R.; Hoffman, T.J.; Sieckman, G.L.; Figueroa, S.D.; and Smith, C.J., The Proceedings of the National Academy of Sciences USA, 104 (30), 12462, 2007

“Organometallic 99mTc(III) 4+1 Bombesin(7-14)NH2 Conjugates: Synthesis, Radiolabeling, and In Vitro/In Vivo Studies.”, Kunstler, J-U.; Veerendra, B.; Figueroa, S.D.; Sieckman, G.L.; Rold, T.L.; Hoffman, T.J.; Smith, C.J.; and Pietzsch, H.J., Bioconjugate Chem., 18, 1651, 2007

“In Vitro and In Vivo Evaluation of Alexa Fluor 680-BBN[7-14]NH2 Peptide Conjugate; A High-affinity Fluorescent Probe Having High Selectivity for the GRP Receptor.”, Ma, L.; Yu, P.; Veerendra, B.; Rold, T.L.; Retzloff, L.; Prasanphanich, A.; Sieckman, G.; Hoffman, T.J.; Volkert, W.A.; and Smith, C.J., Molecular Imaging, 6 (3), 171, 2007

“99mTc(CO)3-Pyrazolyl Conjugates of RGD: In Vitro and In Vivo Evaluation of [99mTcL(CO)3-Cyclo[Arg-Gly-Asp-D-Tyr-Lys]] (L = A Tridentate Pyrazolyl-based Chelating Ligand Framework).”, Alves, S.; Correia, J.D.G.; Rold, T.L.; Prasanphanich, A.; Haubner, R.; Rupprich, M.; von Guggenberg, E.; Alberto, R.; Decristoforo, C.; Santos, I.; and Smith, C.J., Bioconjugate Chem., 18, 530, 2007

“The Effects of Linking Substituents on the In Vivo Behavior of Site-directed, Peptide-based, Diagnostic Radiopharmaceuticals.”, Prasanphanich, A.; Lane, S.R.; Figueroa, S.D.; Ma, L.; Rold, T.L.; Sieckman, G.L.; Hoffman, T.J.; McCrate, J.M.; and Smith, C.J., In Vivo. International Journal of Experimental and Clinical Pathophysiology and Drug Research, 21 (2), 3, 2007

“Comparison of In Vitro and In Vivo Properties of 99mTc-RGD Peptides Labeled Using Different Novel Tc-cores.”, Decristoforo, C.; Santos, I.; Pietzsch, H.J.; Duatti, A.; Smith, C.J.; Faintuch, B.L.; Rey, A.; Alberto, R.; von Guggenberg, E.; and Haubner, R., The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 51 (1), 33, 2007

“Nanocompatible chemistry toward fabrication of target-specific gold nanoparticles”, Kannan, R., Rahing, V., Cutler, C., Pandrapragada, R., Katti, K.K., Kattumuri, V., Robertson, J.D., Casteel, S.J., Jurisson, S., Smith, C., Boote, E., Katti, K.V., Journal of the American Chemical Society, 128, 11342, 2006

“Hybrid gold nanoparticles in molecular imaging and radiotherapy”, Katti, K.V., Kannan, R., Katti, K., Kattumori, V., Pandrapraganda, R., Rahing, V., Cutler, C., Boote, E.J., Casteel, S.W., Smith, C.J., Robertson, J.D., Jurrison, S.S., Czechoslovak Journal of Physics, 56, D23, 2006

“Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: Biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu”, Mohsin, H., Jia, F., Sivaguru, G., Hudson, M.J., Shelton, T.D., Hoffman, T.J., Cutler, C.S., Ketring, A.R., Athey, P.S., Simón, J., Frank, R.K., Jurisson, S.S., Lewis, M.R., Bioconjugate Chemistry, 17, 485, 2006

“Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin”, Moustapha, M.E., Ehrhardt, G.J., Smith, C.J., Szajek, L.P., Eckelman, W.C., Jurisson, S.S., Nuclear Medicine and Biology, 33, 81, 2006

“Neutron activation analysis of the biodistribution of gum arabic gold nanoparticles in swine”, Robertson, J.D., Kannan, R., Katti, K.V., Pent, G.M., Dunsmore, M.E., Casteel, S.W., Transactions of the American Nuclear Society, 95, 457, 2006

“Targeted PARACEST nanoparticle contrast agent for the detection of fibrin”, Winter, P.M., Cai, K., Chen, J., Adair, C.R., Kiefer, G.E., Athey, P.S., Gaffney, P.J., Buff, C.E., Robertson, J.D., Caruthers, S.D., Wickline, S.A., Lanza, G.M., Magnetic Resonance in Medicine, 56, 1384, 2006

“Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis”, Winter, P.M., Neubauer, A.M., Caruthers, S.D., Harris, T.D., Robertson, J.D., Williams, T.A., Schmieder, A.H., Hu, G., Allen, J.S., Lacy, E.K., Zhang, H., Wickline, S.A., Lanza, G.M., Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2103, 2006

“Synthesis, Radiolabeling and In vitro GRP Receptor Targeting Studies of 99mTc-Triaza-X-BBN[7-14]NH2 (X = Serylserylserine, Glycylglycylglycine, Glycylserylglycine, or Beta Alanine).”, Veerendra, B.; Sieckman, G.L.; Hoffman, T.J.; Rold, T.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; and Smith C.J., Journal of Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-metal Compounds, 36 (6), 481, 2006

“Evaluation of Combined 177Lu-DOTA-8-AOC-BBN(7-14)NH2 GRP Receptor Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell Xenografted SCID Mice.”, Johnson, C.V.; Shelton, T.D; Smith,C.J.; Ma, L.; Perry, M.C.; Volkert, W.A.; and Hoffman, T.J., Cancer Biotherapy & Radiopharmaceuticals, 21 (2), 155, 2006

“Preparation of Cyclotron-Produced Re-186 and Comparison with Reactor-Produced Re-186 and Generator-Produced Re-188 for the Labeling of Bombesin.”, Moustapha, M.E.; Ehrhardt, G.J.; Smith, C.J.; Szajek, L.; Eckelman, W.C.; and Jurisson, S.J., Nucl. Med. Biol., 33 (1), 81, 2006

“Pyrazolyl Conjugates of Bombesin: A New Tridentate Ligand Framework for Stabilization of the fac-MI(CO)3 Moiety.”, Alves, S.; Santos, I.; Bhadrasetty, V.; Correia, J.D.G.; Sieckman, G.L.; Hoffman, T.J.; Rold, T.; Figueroa, S.D.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; and Smith, C.J., Nucl. Med. Biol., 33 (5), 625, 2006

“Solid state study on rhenium dimethylphosphinoethane complexes: X-ray crystal structures of trans-[ReO2 (dmpe)2]PF6·2H2O, trans-[ReO(OH)(dmpe)2](CF 3SO3)2, trans-[ReN(Cl)(dmpe) 2]CF3SO3 and trans-[ReCl2(dmpe) 2]ReO4”, Engelbrecht, H.P., Jurisson, S.S., Cutler, C.S., Den Drijver, L., Roodt, A., Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry, 35, 83, 2005

“Characterization and biodistribution of a novel MRI molecular imaging agent by neutron activation analysis”, Robertson, J.D., Crane, S.B., Wickline, S.A., Lanza, G.M., Journal of Radioanalytical and Nuclear Chemistry, 263, 511, 2005

“Molecular MR imaging of melanoma angiogenesis with αvβ3-targeted paramagnetic nanoparticles”, Schmieder, A.H., Winter, P.M., Caruthers, S.D., Harris, T.D., Williams, T.A., Allen, J.S., Lacy, E.K., Zhang, H., Scott, M.J., Hu, G., Robertson, J.D., Wickline, S.A., Lanza, G.M., Magnetic Resonance in Medicine, 53, 621, 2005

“Structural determination of 99Tc radiopharmaceuticals and compounds using X-ray absorption spectroscopy”, Terry, J., Grzenia, B., Papagiannopoulou, D., Kyger, J., Jurisson, S., Robertson, J.D., Journal of Radioanalytical and Nuclear Chemistry, 263, 531, 2005

“Molecular imaging of human thrombus with computed tomography”, Winter, P.M., Shukla, H.P., Caruthers, S.D., Scott, M.J., Fuhrhop, R.W., Robertson, J.D., Gaffney, P.J., Wickline, S.A., Lanza, G.M., Academic Radiology, 12, S9, 2005

“Erratum: Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice (Nuclear Medicine and Biology 31:2 (213-223))”, Lewis, M.R., Zhang, J., Jia, F., Owen, N.K., Cutler, C.S., Embree, M.F., Schultz, J., Theodore, L.J., Ketring, A.R., Jurisson, S.S., Axworthy, D.B., Nuclear Medicine and Biology, 31, 973, 2004

“Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice”, Lewis, M.R., Zhang, J., Jia, F., Owen, N.K., Cutler, C.S., Embree, M.F., Schultz, J., Theodore, L.J., Ketring, A.R., Jurisson, S.S., Axworthy, D.B., Nuclear Medicine and Biology, 31, 213, 2004

“Targeted Nanoparticles for Quantitative Imaging of Sparse Molecular Epitopes with MRI”, Morawski, A.M., Winter, P.M., Crowder, K.C., Caruthers, S.D., Fuhrhop, R.W., Scott, M.J., Robertson, J.D., Abendschein, D.R., Lanza, G.M., Wickline, S.A., Magnetic Resonance in Medicine, 51, 480, 2004

“Quantitative “magnetic resonance immunohistochemistry”with ligand-targeted 19F nanoparticles”, Morawski, A.M., Winter, P.M., Yu, X., Fuhrhop, R.W., Scott, M.J., Hockett, F., Robertson, J.D., Gaffney, P.J., Lanza, G.M., Wickline, S.A., Magnetic Resonance in Medicine, 52, 1255, 2004

“Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm”, Li, W.P., Smith, C.J., Cutler, C.S., Hoffman, T.J., Ketring, A.R., Jurisson, S.S., Nuclear Medicine and Biology, 30, 241, 2003

“Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel αvβ3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging”, Winter, P.M., Caruthers, S.D., Kassner, A., Harris, T.D., Chinen, L.K., Allen, J.S., Lacy, E.K., Zhang, H., Robertson, J.D., Wickline, S.A., Lanza, G.M., Cancer Research, 63, 5838, 2003

“Improved molecular imaging contrast agent for detection of human thrombus”, Winter, P.M., Caruthers, S.D., Yu, X., Song, S.-K., Chen, J., Miller, B., Bulte, J.W.M., Robertson, J.D., Gaffney, P.J., Wickline, S.A., Lanza, G.M., Magnetic Resonance in Medicine, 50, 411, 2003

“Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With alpha(v)beta3-Integrin-Targeted Nanoparticles”, Winter, P.M., Morawski, A.M., Caruthers, S.D., Fuhrhop, R.W., Zhang, H., Williams, T.A., Allen, J.S., Lacy, E.K., Robertson, J.D., Lanza, G.M., Wickline, S.A., Circulation, 108, 2270, 2003

“Pm-149 DOTA bombesin analogs for potential radiotherapy: In vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-βAla-BBN(7-14)NH2”, Hu, F., Cutler, C.S., Hoffman, T., Sieckman, G., Volkert, W.A., Jurisson, S.S., Nuclear Medicine and Biology, 29, 423, 2002

“In vitro and in vivo dissolution behavior of a dysprosium lithium borate glass designed for the radiation synovectomy treatment of rheumatoid arthritis”, Conzone, S.D., Brown, R.F., Day, D.E., Ehrhardt, G.J., Journal of Biomedical Materials Research, 60, 260, 2002

“Syntheses and characterization of gold(III) tetradentate schiff base complexes. X-ray crystal structures of [Au(sal2pn)]Cl2.5H2O and [Au(sal2en)]PF6”, Barnholtz, S.L., Lydon, J.D., Huang, G., Venkatesh, M., Barnes, C.L., Ketring, A.R., Jurisson, S.S., Inorganic Chemistry, 40, 972, 2001

“Development of an in vitro model for assessing the in vivo stability of lanthanide chelates”, Li, W.P., Ma, D.S., Higginbotham, C., Hoffman, T., Ketring, A.R., Cutler, C.S., Jurisson, S.S., Nuclear Medicine and Biology, 28, 145, 2001

“Current and potential therapeutic uses of lanthanide radioisotopes”, Cutler, C.S., Smith, C.J., Ehrhardt, G.J., Tyler, T.T., Jurisson, S.S., Deutsch, E., Cancer Biotherapy and Radiopharmaceuticals, 15, 531, 2000

“Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes”, Cutler, C.S., Wuest, M., Anderson, C.J., Reichert, D.E., Sun, Y., Martell, A.E., Wekh, M.J., Nuclear Medicine and Biology, 27, 375, 2000

“Production of No-Carrier-Added 105Rh from Neutron Irradiated Ruthenium Target”, Jia, W., Ma, D., Volkert, E.W., Ketring, A.R., Ehrhardt, G.J., Jurisson, S.S., Platinum Metals Review, 44, 50, 2000

“Rhodium (III) complexes with acyclic tetrathioether ligands: Potential bifunctional chelates for use in radiotherapy”, Hu, F., Lydon, J.D., Jurisson, S., Ketring, A., Journal of Labelled Compounds and Radiopharmaceuticals, 42, S818, 1999

“Development of an in vitro model for assessing the in vivo stability of lanthanide chelates”, Li, W.P., Ma, D.S., Jurisson, S.S., Ketring, A.R., Journal of Labelled Compounds and Radiopharmaceuticals, 42, S243, 1999

“Preparation of 105 Rh labeled monoclonal antibody (MAb B72.3) using aminobenzylpropyleneamineoxime as the bifunctional chelating agent; Comparison to 131 I labeled MAb B72.3”, Venkatesh, M., Schlemper, E.O., Jurisson, S.S., Ketring, A.R., Volkert, W.A., Corlija, M., Radiochimica Acta, 85, 157, 1999

“Metallofullerene drug design”, Wilson, L.J., Cagle, D.W., Thrash, T.P., Kennel, S.J., Mirzadeh, S., Alford, J.M., Ehrhardt, G.J., Coordination Chemistry Reviews, 190, 199, 1999

“Metallofullerene drug design”, Wilson, L.J., Cagle, D.W., Thrash, T.P., Kennel, S.J., Mirzadeh, S., Alford, J.M., Ehrhardt, G.J., Coordination Chemistry Reviews, 191, 199, 1999

“Metallofullerene drug design”, Wilson, L.J., Cagle, D.W., Thrash, T.P., Kennel, S.J., Mirzadeh, S., Alford, J.M., Ehrhardt, G.J., Coordination Chemistry Reviews, 192, 199, 1999

“Investigation of recoil collection method for production of high specific activity nuclear medicine isotopes”, Cheng, K.-Y., Kunze, J.F., Ehrhardt, G.J., Medical Physics, 26, 1843, 1999

“Toward fullerene-based radiopharmaceuticals: High-yield neutron activation of endohedral 165Ho metallofullerenes”, Thrash, T.P., Cagle, D.W., Alford, J.M., Wright, K., Ehrhardt, G.J., Mirzadeh, S., Wilson, L.J., Chemical Physics Letters, 308, 329, 1999

“198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals”, Berning, D.E., Katti, K.V., Volkert, W.A., Higginbotham, C.J., Ketring, A.R., Nuclear Medicine and Biology, 25, 577, 1998

“Reactor-produced radionuclides at the University of Missouri Research Reactor”, Ehrhardt, G.J., Ketring, A.R., Ayers, L.M., Applied Radiation and Isotopes, 49, 295, 1998

“Rhenium-188(Sn)HEDP for treatment of osseous metastases”, Maxon III, H.R., Schroder, L.E., Washburn, L.C., Thomas, S.R., Samaratunga, R.C., Biniakiewicz, D., Moulton, J.S., Cummings, D., Ehrhardt, G.J., Morris, V., Journal of Nuclear Medicine, 39, 659, 1998

“Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy”, Conzone, S.D., Haifeli, U.O., Day, D.E., Ehrhardt, G.J., Journal of Biomedical Materials Research, 42, 617, 1998

“Chemistry in Environmentally Benign Media. 7.1 Chelating Hydroxymethyl-Functionalized Bisphosphines as Building Blocks to Water-Soluble and in-Vitro-Stable Gold(I) Complexes. Synthesis, Characterization, and X-ray Crystal Structures of [Au{(HOH2C)2PC6H 4P(CH2OH)2}2]Cl”, Berning, D.E., Katti, K.V., Barnes, C.L., Volkert, W.A., Ketring, A.R., Inorganic Chemistry, 36, 2765, 1997

“Experience with aluminum perrhenate targets for reactor production of high specific activity Re-186”, Ehrhardt, G.J., Blumer, M.E., Su, F.M., Vanderheyden, J.L., Fritzberg, A.R., Applied Radiation and Isotopes, 48, 1, 1997

“Rhodium-105 complexes as potential radiotherapeutic agents”, Jurisson, S.S., Ketring, A.R., Volkert, W.A., Transition Metal Chemistry, 22, 315, 1997

“Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats”, Li, N., Struttman, M., Higginbotham, C., Grall, A.J., Skerlj, J.F., Vollano, J.F., Bridger, S.A., Ochrymowycz, L.A., Ketring, A.R., Abrams, M.J., Volkert, W.A., Nuclear Medicine and Biology, 24, 85, 1997

“Effect of Stoichiometric and Preparation Parameters on W-188/Re-188 Gel Generator Performance”, Liang, Q., Ehrhardt, G.J., Ketring, A.R., Miller, R., Radiochimica Acta, 79, 137, 1997

“Enhancing the Specific Activity of 186Re Using an Inorganic Szilard-Chalmers Process”, Jia, W., Ehrhardt, G.J., Radiochimica Acta, 79, 131, 1997

“186Re/188Re labeled polypeptide microspheres as a potential radiation synovectomy agent”, Jia, W., Ehrhardt, G.J., Zinn, K., Wang, N., Ketring, A.R., Journal of Radioanalytical and Nuclear Chemistry, 206, 107, 1996

“Comparisons of 105Rh(III) Chloride Complexation with [14]aneNS3, [14]aneN2S2 and [14]aneN4 Macrocycles in Aqueous Solution”, Li, N., Eberlein, C.M., Volkert, W.A., Ochrymowycz, L., Barnes, C., Ketring, A.R., Radiochimica Acta, 75, 83, 1996

“Production of radiolanthanides and radiotherapy research at MURR”, Ma, D., Ketring, A.R., Ehrhardt, G.J., Jia, W., Journal of Radioanalytical and Nuclear Chemistry, 206, 119, 1996

“Chemistry in Environmentally Benign Media. 3.1 Synthesis and Characterization of Rhenium(V) Complexes Derived from Novel Water-Soluble (Hydroxymethyl)phosphines.”, Reddy, V.S., Beriung, D.E., Katti, K.V., Barnes, C.L., Volkert, W.A., Ketring, A.R., Inorganic Chemistry, 35, 1753, 1996

“An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates”, Venkatesh, M., Goswami, N., Volkert, W.A., Schlemper, E.O., Ketring, A.R., Barnes, C.L., Jurisson, S., Nuclear Medicine and Biology, 23, 33, 1996

“Synthesis, characterization, and neutron activation of holmium metallofullerenes”, Cagle, D.W., Thrash, T.P., Alford, M., Felipe Chibante, L.P., Ehrhardt, G.J., Wilson, L.J., Journal of the American Chemical Society, 118, 8043, 1996

“Synthesis and characterization of a neutral and lipophilic Ph3PN99mTcO3 complex”, Katti, K.K., Singh, P.R., Volkert, W.A., Anderson, C.J., Welch, M.J., Hoffman, T., Katti, K.V., Ketring, A.R., Wang, M., Applied Radiation and Isotopes, 46, 53, 1995

“Transition metal chemistry of main group hydrazides, part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides”, Singh, P.R., Lusiak, P., Volkert, W.A., Ketring, A.R., Holmes, R.A., Katti, K.V., Nuclear Medicine and Biology, 22, 849, 1995

“A new 99mTc-complex with a germanium-hydrazide (GeTH) ligand”, Singh, P.R., Katti, K.K., Katti, K.V., Corlija, M., Ketring, A.R., Volkert, W.A., Holmes, R.R., Nuclear Medicine and Biology, 21, 1115, 1994

“Production of no-carrier-added 64Cu from zinc metal irradiated under boron shielding”, Zinn, K.R., Chaudhuri, T.R., Cheng, T.-P., Morris, J.S., Meyer Jr., W.A., Cancer, 73, 774, 1994

“Unsymmetrical phosphorus hydrazide chelating systems as potential BFCA’s for proteins and peptides”, Volkert, W.A., Hoffman, T.J., Corlija, M., Singh, P.R., Jimenez, H., Katti, K.K., Katti, K.V., Lusiak, P., Ketring, A.R., Holmes, R.A., Journal of Labelled Compounds and Radiopharmaceuticals, 35, 3, 1994

“Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP”, Appelbaum, F.R., Brown, P.A., Sandmaier, B.M., Storb, R., Fisher, D.R., Shulman, H.M., Graham, T.C., Schuening, F.G., Deeg, H.J., Bianco, J.A., Ketring, A.R., Kaplan, D., Blood, 80, 1608, 1992

“Technetium- and rhenium-labeled progestins: Synthesis, receptor binding and in vivo distribution of an 11 β-substituted progestin labeled with technetium-99 and rhenium-186”, DiZio, J.P., Anderson, C.J., Davison, A., Ehrhardt, G.J., Carlson, K.E., Welch, M.J., Katzenellenbogen, J.A., Journal of Nuclear Medicine, 33, 558, 1992

“Calculation of radiation dose at a bone-to-marrow interface using Monte Carlo modeling techniques (EGS4)”, Johnson, J.C., Langhorst, S.M., Loyalka, S.K., Volkert, W.A., Ketring, A.R., Journal of Nuclear Medicine, 33, 623, 1992

“A new neutral-lipophilic 99mTc complex with a bis-hydrazide-phosphine (BHP) ligand”, Katti, K.V., Singh, P.R., Volkert, W.A., Ketring, A.R., Katti, K.K., Applied Radiation and Isotopes, 43, 1151, 1992

“Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases”, Maxon III, H.R., Thomas, S.R., Hertzberg, V.S., Schroder, L.E., Englaro, E.E., Samaratunga, R., Scher, H.I., Moulton, J.S., Deutsch, E.A., Deutsch, K.F., Schneider, H.J., Williams, C.C., Ehrhardt, G.J., Seminars in Nuclear Medicine, 22, 33, 1992

“Synthesis, characterization and biodistribution studies of a neutral-lipophilic Tc-99m N3S2 chelate”, Singh, P.R., Corlija, M., Troutner, D.E., Ketring, A.R., Volkert, W.A., International Journal of Radiation Applications and Instrumentation., 19, 791, 1992

“Calculation of the radiation dose at a bone-to-marrow interface [4]”, Van Dieren, E.B., Plaizier, M.A.B.D., Roos, J.C., Teule, G.J.J., Van Lingen, A., Johnson, J.C., Langhorst, S.M., Loyalka, S.K., Volkert, W.A., Ketring, A.R., Journal of Nuclear Medicine, 33, 1915, 1992

“Radioisotope generators for nuclear medicine based on Fajans adsorption on glass microspheres”, Ehrhardt, G.J., Symes, S., Guimon, R.K., Zinn, K.R., Nuclear Science and Engineering, 110, 369, 1992

“New apparatus for measuring radon adsorption on solid adsorbents”, Hassan, N.M., Hines, A.L., Ghosh, T.K., Loyalka, S.K., Ketring, A.R., Industrial & Engineering Chemistry Research, 30, 2205, 1991

“Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: Results of a double-blind crossover comparison with placebo”, Maxon III, H.R., Schroder, L.E., Hertzberg, V.S., Thomas, S.R., Englaro, E.E., Samaratunga, R., Smith, H., Moulton, J.S., Williams, C.C., Ehrhardt, G.J., Schneider, H.J., Journal of Nuclear Medicine, 32, 1877, 1991

“Therapeutic radionuclides: Production and decay property considerations”, Volkert, W.A., Goeckeler, W.F., Ehrhardt, G.J., Ketring, A.R., Journal of Nuclear Medicine, 32, 174, 1991

“Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP”, Lattimer, J.C., Corwin Jr., L.A., Stapleton, J., Volkert, W.A., Ehrhardt, G.J., Ketring, A.R., Anderson, S.K., Simon, J., Goeckeler, W.F., Journal of Nuclear Medicine, 31, 1316, 1990

“Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs”, Lattimer, J.C., Corwin Jr., L.A., Stapleton, J., Volkert, W.A., Ehrhardt, G.J., Ketring, A.R., Hewett, J.E., Simon, J., Goeckeler, W.F., Journal of Nuclear Medicine, 31, 586, 1990

“Erratum: Synthesis and characterization of cationic technetium complexes of 1,2-bis(dimethylphosphino)ethane (DMPE). Structure determinations of trans-[TcV(DMPE)2(OH)(O)](F3CSO 3)2, trans-[TcIII(DMPE)2Cl2]F3CSO 3, and [TcI(DMPE) …”, Vanderheyden, J.-L., Ketring, A.R., Libson, K., Heeg, M.J., Roecker, L., Motz, P., Whittle, R., Elder, R.C., Deutsch, E., Inorganic Chemistry, 29, 4840, 1990

“Therapeutic use of 90Y microspheres”, Ehrhardt, G.J., Day, D.E., International Journal of Radiation Applications and Instrumentation., 14, 233, 1987

“Labeling of antibodies with 64Cu using a conjugate containing a macrocyclic amine chelating agent”, Franz, J., Freeman, G.M., Barefield, E.K., Volkert, W.A., Ehrhardt, G.J., Holmes, R.A., International Journal of Radiation Applications and Instrumentation., 14, 479, 1987

“Production of Sm-153 for radiotherapeutic applications”, Ehrhardt, G.J., Ketring, A.R., Volkert, W.A., Journal of Labelled Compounds and Radiopharmaceuticals, 23, 1370, 1986

“Use of radioisotopes (1-92) made at a steady state neutron facility”, Yelon, W.B., Ehrhardt, G.J., Brugger, R.M., Nuclear Inst. and Methods in Physics Research, Section A, 249, 20, 1986

“A new Cd-115 → In-115m radionuclide generator”, Ehrhardt, G.J., Volkert, W., Goeckeler, W.F., Kapsch, D.N., Journal of Nuclear Medicine, 24, 349, 1983

“POSITRON TOMOGRAPHIC IMAGING OF THE LIVER WITH Ga-68 IRON HYDROXIDE COLLOID.”, Kumar, Bharath, Miller, Tom R., Siegel, Barry A., Mathias, Carla J., Markham, Joanne, Ehrhardt, Gary J., Welch, Michael J., Proceedings of the Society of Photo-Optical Instrumentation Engineers, 233, 248, 1980

“Applications of gallium-68 produced by the gallium-68 oxine generator”, Ehrhardt, G., Wagner, S., Welch, M.J., Journal of Labelled Compounds and Radiopharmaceuticals, 16, 111, 1979

“A new germanium-68/gallium-68 generator”, Ehrhardt, G.J., Welch, M.J., Journal of Nuclear Medicine, 19, 925, 1978